Phase III clinical data from BE VIVID and BE READY studies of bimekizumab presented at AAD for treatment of psoriasis.- UCB.

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest